| h-debate-798ab8caa6e | Microglial NLRP3 Inflammasome as Circadian-Specific Drug Target | 0.00 | 0.55 | NLRP3 inflammasome / BMAL1 | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095945-976d542d |
| h-debate-5522db93188 | P2Y12 Receptor-Mediated Phase Resetting of Circadian Inflammatory Rhythms | 0.00 | 0.55 | P2Y12 / BMAL1-CLOCK complex | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095945-976d542d |
| h-debate-d5862b41ad6 | Bile Acid Signaling Disruption Cascade | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-c77ea962308 | Prevotellaceae as Dopamine Precursor Modulators | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-8dff48967c6 | Circadian Rhythm Disruption via Microbiome-Clock Axis | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-2af67e4bdf2 | Systemic Metabolic Reprogramming via Prevotellaceae Loss | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-02154a51ed0 | Prevotellaceae-Mediated Enteric Nervous System Priming Theory | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-fe250a01715 | Immune Tolerance Breakdown via Prevotellaceae Depletion | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-d4c2b39b6fb | Prevotellaceae Metabolite Depletion as Alpha-Synuclein Aggregation Catalyst | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-3f89ad537dc | Synaptic Membrane Domain Stabilizers | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-01-gap-lipid-rafts-2026-04-01 |
| h-debate-8714730f4b4 | Membrane Fluidity Gradient Therapeutics | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-01-gap-lipid-rafts-2026-04-01 |
| h-debate-32048e06955 | Cholinergic-Lipid Raft Interface Modulators | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-01-gap-lipid-rafts-2026-04-01 |
| h-debate-003655d0810 | Synaptic Raft Rejuvenation via Ceramide Metabolism | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-01-gap-lipid-rafts-2026-04-01 |
| h-debate-147b6ec96c2 | APP Processing Compartmentalization Therapeutics | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-01-gap-lipid-rafts-2026-04-01 |
| h-debate-72ba8ec8205 | Cholesterol-Sphingolipid Ratio Modulators as Synaptic Rescuers | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-01-gap-lipid-rafts-2026-04-01 |
| h-debate-5dba64cf979 | Nicotinic Receptor-Lipid Raft Co-Modulators | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-01-gap-lipid-rafts-2026-04-01 |
| h-debate-8065828c364 | Bi-functional Nuclear Trafficking-Phase Separation Modulators | 0.00 | 0.55 | TARDBP | proposed | 2026-04-29 | sda-2026-04-01-gap-006 |
| h-debate-07f363d7e98 | C-Terminal Frameshift Protection via RNA-Guided Editing | 0.00 | 0.55 | TARDBP | proposed | 2026-04-29 | sda-2026-04-01-gap-006 |
| h-debate-ca7cd06fbe9 | Membraneless Organelle Stabilizers Targeting Low-Complexity Domains | 0.00 | 0.55 | TARDBP | proposed | 2026-04-29 | sda-2026-04-01-gap-006 |
| h-debate-cc1a80961f9 | G4C2 RNA Decoy Therapeutics | 0.00 | 0.55 | C9orf72 | proposed | 2026-04-29 | sda-2026-04-01-gap-006 |
| h-debate-bccf51838ea | Phase Transition Kinetics Modulators | 0.00 | 0.55 | TARDBP | proposed | 2026-04-29 | sda-2026-04-01-gap-006 |
| h-debate-2bd1fc31f6e | Nuclear Import Receptor Enhancers as Phase Separation Modulators | 0.00 | 0.55 | TARDBP | proposed | 2026-04-29 | sda-2026-04-01-gap-006 |
| h-debate-516516c6941 | Arginine-Rich DPR Competitive Inhibitors | 0.00 | 0.55 | C9orf72 | proposed | 2026-04-29 | sda-2026-04-01-gap-006 |
| h-debate-6024ce76e0c | Innate Immunity Memory Erasure Protocol | 0.00 | 0.55 | KDM1A | proposed | 2026-04-29 | SDA-2026-04-04-gap-epigenetic-reprog-b685190e |
| h-debate-73c94b586b3 | Synaptic Chromatin Compartment Rejuvenation | 0.00 | 0.55 | CREBBP | proposed | 2026-04-29 | SDA-2026-04-04-gap-epigenetic-reprog-b685190e |
| h-debate-e1f2c6598ff | Partial Reprogramming with Chromatin Velocity Control | 0.00 | 0.55 | BRD4 | proposed | 2026-04-29 | SDA-2026-04-04-gap-epigenetic-reprog-b685190e |
| h-debate-0aa85875f42 | Temporal Chromatin Oscillator Reset Therapy | 0.00 | 0.55 | KLF4 | proposed | 2026-04-29 | SDA-2026-04-04-gap-epigenetic-reprog-b685190e |
| h-debate-70b72b9966d | Epigenetic Clock Reversal via Metabolic Oscillator Coupling | 0.00 | 0.55 | SIRT1 | proposed | 2026-04-29 | SDA-2026-04-04-gap-epigenetic-reprog-b685190e |
| h-debate-4e3485ffd63 | Metabolic-Epigenetic Coupling Restoration via ApoE Mimetics | 0.00 | 0.55 | APOE | proposed | 2026-04-29 | SDA-2026-04-04-gap-epigenetic-reprog-b685190e |
| h-debate-9a99b2c74b6 | Glial-Neuronal Epigenetic Cross-Talk Restoration | 0.00 | 0.55 | APOE | proposed | 2026-04-29 | SDA-2026-04-04-gap-epigenetic-reprog-b685190e |
| h-debate-c209826cba1 | Synthetic Biology Circuits for Network Homeostasis | 0.00 | 0.55 | Network homeostasis machinery | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47 |
| h-debate-25cee9bfa90 | Optogenetic Control of Protein Interactions | 0.00 | 0.55 | Disease-affected interaction proteins | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47 |
| h-debate-6ece528a0b9 | Proximity-Induced Degradation of Mislocalized Proteins | 0.00 | 0.55 | Mislocalized disease proteins | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47 |
| h-debate-58f24b61f38 | Synthetic Compartmentalization Therapy | 0.00 | 0.55 | Compartmentalization machinery | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47 |
| h-debate-8523fd7b01e | RNA-Guided Subcellular Protein Targeting | 0.00 | 0.55 | Mislocalized disease proteins | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47 |
| h-debate-52d41369285 | Chaperone-Mediated Interaction Rescue | 0.00 | 0.55 | Disease-specific interaction domains | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47 |
| h-debate-4f9f0b3525b | Small Molecule Interaction Stabilizers | 0.00 | 0.55 | Multiple interaction hub proteins | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47 |
| h-debate-ba7fcef7263 | Phase Separation Modifier Compounds | 0.00 | 0.55 | Multiple condensate proteins | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca |
| h-debate-9b9a295107b | Multivalent RNA-Binding Domain Inhibitors | 0.00 | 0.55 | TP53BP1 | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca |
| h-debate-b6249bf13b7 | Preinitiation Complex Assembly Modulators | 0.00 | 0.55 | TBP | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca |
| h-debate-96b36f67bd3 | RNA Polymerase II CTD Phosphatase Modulators | 0.00 | 0.55 | POLR2A | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca |
| h-debate-8afcc11e534 | RNA-Dependent Condensate Maturation Inhibitors | 0.00 | 0.55 | Multiple DDR proteins | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca |
| h-debate-e7034c03db5 | MRN Complex-PIC Interaction Disruptors | 0.00 | 0.55 | RAD50 | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca |
| h-debate-10550664d87 | Sequence-Specific RNA Antisense Oligonucleotides (ASOs) for dilncRNA Depletion | 0.00 | 0.55 | dilncRNAs | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca |
| h-debate-772daf86516 | RNA Aptamer-Mediated Therapeutic Condensate Hijacking | 0.00 | 0.55 | 53BP1 | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95 |
| h-debate-52884dbaab7 | Condensate Permeability Modulators for Protein Quality Control | 0.00 | 0.55 | 53BP1 | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95 |
| h-debate-151eb035421 | Multivalent Decoy Proteins for Condensate Redirection | 0.00 | 0.55 | SNCA | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95 |
| h-debate-7b80773c106 | RNA-Guided Condensate Reprogramming for Neuroprotection | 0.00 | 0.55 | 53BP1 | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95 |
| h-debate-3eb94204c34 | Aberrant Condensate Dissolution Therapy | 0.00 | 0.55 | 53BP1 | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95 |
| h-debate-fbca3a2cb8e | IDR Competition Therapy | 0.00 | 0.55 | MAPT | proposed | 2026-04-29 | SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95 |